| 21/07/20 | 15:00:04 | 21 Jul 2020 | | Holding(s) in Company | RNS |
| 21/07/20 | 15:00:04 | 21 Jul 2020 | | Holding(s) in Company | RNS |
| 20/07/20 | 14:41:34 | 20 Jul 2020 | | COVID-19 vaccine Phase I/II showed immune response | RNS |
| 16/07/20 | 07:00:05 | 16 Jul 2020 | | Director Declaration | RNS |
| 09/07/20 | 07:00:07 | 9 Jul 2020 | | Brilinta granted US FDA Priority Review for stroke | RNS |
| 08/07/20 | 07:00:05 | 8 Jul 2020 | | Lynparza approved in the EU for pancreatic cancer | RNS |
| 01/07/20 | 15:00:01 | 1 Jul 2020 | | Total Voting Rights | RNS |
| 30/06/20 | 15:00:01 | 30 Jun 2020 | | Director/PDMR Shareholding | RNS |
| 30/06/20 | 07:00:07 | 30 Jun 2020 | | Selumetinib granted Japan orphan drug designation | RNS |
| 17/06/20 | 15:03:07 | 17 Jun 2020 | | Holding(s) in Company | RNS |
| 17/06/20 | 15:00:05 | 17 Jun 2020 | | Holding(s) in Company | RNS |
| 15/06/20 | 07:00:08 | 15 Jun 2020 | | Agreement to Supply Europe with COVID-19 Vaccine | RNS |
| 11/06/20 | 07:00:07 | 11 Jun 2020 | | EMTN Programme Routine Technical Update | RNS |
| 01/06/20 | 15:00:01 | 1 Jun 2020 | | Total Voting Rights | RNS |
| 01/06/20 | 15:00:01 | 1 Jun 2020 | | Block listing Interim Review | RNS |
| 01/06/20 | 07:00:08 | 1 Jun 2020 | | Lynparza EU CHMP opinion in pancreatic cancer | RNS |
| 01/06/20 | 07:00:08 | 1 Jun 2020 | | Brilinta obtains additional US approval | RNS |
| 29/05/20 | 16:41:31 | 29 May 2020 | | Second Price Monitoring Extn | RNS |
| 29/05/20 | 16:35:53 | 29 May 2020 | | Price Monitoring Extension | RNS |
| 29/05/20 | 13:00:05 | 29 May 2020 | | Enhertu DESTINY-Gastric01 results from ASCO 2020 | RNS |
| 29/05/20 | 13:00:05 | 29 May 2020 | | Imfinzi sustained overall survival in CASPIAN | RNS |
| 29/05/20 | 07:00:07 | 29 May 2020 | | Tagrisso unprecedented adjuvant lung cancer data | RNS |
| 26/05/20 | 10:30:03 | 26 May 2020 | | Director/PDMR Shareholding | RNS |
| 22/05/20 | 07:00:06 | 22 May 2020 | | Enhertu US orphan designation in gastric cancer | RNS |
| 21/05/20 | 07:00:10 | 21 May 2020 | | AstraZeneca advances response to COVID-19 outbreak | RNS |
| 20/05/20 | 07:00:04 | 20 May 2020 | | Lynparza approved in the US for prostate cancer | RNS |
| 18/05/20 | 07:00:08 | 18 May 2020 | | Enhertu US Breakthrough status for lung cancer | RNS |
| 18/05/20 | 07:00:08 | 18 May 2020 | | Bevespi Aerosphere approved in China for COPD | RNS |
| 11/05/20 | 07:00:11 | 11 May 2020 | | Enhertu designated gastric cancer BTD | RNS |
| 11/05/20 | 07:00:11 | 11 May 2020 | | Brazikumab rights recovered by AstraZeneca | RNS |
| 11/05/20 | 07:00:11 | 11 May 2020 | | Lynparza gets broader US ovarian cancer approval | RNS |
| 06/05/20 | 07:00:08 | 6 May 2020 | | Farxiga approved by FDA for heart failure (HFrEF) | RNS |
| 01/05/20 | 15:00:01 | 1 May 2020 | | Total Voting Rights | RNS |
| 29/04/20 | 16:00:08 | 29 Apr 2020 | | Result of AGM | RNS |
| 29/04/20 | 07:00:04 | 29 Apr 2020 | | AZN: first-quarter 2020 results | RNS |
| 24/04/20 | 07:00:03 | 24 Apr 2020 | | Lynparza shows overall survival in prostate cancer | RNS |
| 17/04/20 | 11:00:07 | 17 Apr 2020 | | Changes to arrangements for AGM | RNS |
| 14/04/20 | 07:00:08 | 14 Apr 2020 | | Koselugo (selumetinib) approved in the US for NF1 | RNS |
| 14/04/20 | 07:00:08 | 14 Apr 2020 | | Tagrisso adjuvant trial overwhelmingly positive | RNS |
| 02/04/20 | 08:00:04 | 2 Apr 2020 | | AstraZeneca divestment of Movantik completed | RNS |
| 01/04/20 | 16:00:03 | 1 Apr 2020 | | Total Voting Rights | RNS |
| 31/03/20 | 08:00:07 | 31 Mar 2020 | | Director/PDMR Shareholding | RNS |
| 30/03/20 | 08:01:05 | 30 Mar 2020 | | Imfinzi approved in US for small cell lung cancer | RNS |
| 30/03/20 | 08:00:07 | 30 Mar 2020 | | Farxiga CKD trial early stop for positive efficacy | RNS |
| 26/03/20 | 07:00:03 | 26 Mar 2020 | | Lokelma approved in Japan for hyperkalaemia | RNS |
| 26/03/20 | 07:00:03 | 26 Mar 2020 | | Director/PDMR Shareholding | RNS |
| 24/03/20 | 16:41:20 | 24 Mar 2020 | | Second Price Monitoring Extn | RNS |
| 24/03/20 | 16:36:42 | 24 Mar 2020 | | Price Monitoring Extension | RNS |
| 24/03/20 | 12:02:46 | 24 Mar 2020 | | Price Monitoring Extension | RNS |
| 23/03/20 | 16:40:48 | 23 Mar 2020 | | Second Price Monitoring Extn | RNS |
